Clinical Trial Update: Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection [Phase 3]

View source ↗

Summary

Phase 3 study evaluating moxifloxacin in pediatric patients with complicated intraabdominal infection completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraabdominal Infections

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Intraabdominal Infections | Phase 3 | Status: COMPLETED | Results posted: 2015-12-08